Lyme Arthritis

You have full text access to this OnlineOpen article

Analysis of Borrelia burgdorferi genotypes in patients with lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis

  1. Kathryn L. Jones,
  2. Gail A. McHugh,
  3. Lisa J. Glickstein,
  4. Allen C. Steere*

Article first published online: 29 JUN 2009

DOI: 10.1002/art.24812

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 60, Issue 7, pages 2174–2182, July 2009

Additional Information

How to Cite

Jones, K. L., McHugh, G. A., Glickstein, L. J. and Steere, A. C. (2009), Analysis of Borrelia burgdorferi genotypes in patients with lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis. Arthritis & Rheumatism, 60: 2174–2182. doi: 10.1002/art.24812

Author Information

  1. Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts

*Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, 55 Fruit Street, CNY 149/8301, Boston, MA 02114

Publication History

  1. Issue published online: 29 JUN 2009
  2. Article first published online: 29 JUN 2009
  3. Manuscript Accepted: 26 MAR 2009
  4. Manuscript Received: 22 JAN 2009

Funded by

  • NIH. Grant Numbers: AR-20358, AR-007258
  • English, Bonter, Mitchell Foundation
  • Eshe Fund
  • Lyme/Arthritis Research Fund at Massachusetts General Hospital
  • Scholarship from the Walter J. and Lille A. Berbecker Foundation for the study of Lyme disease

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (92K)

REFERENCES

  • 1
    Steere AC. Lyme disease. N Engl J Med 2001; 345: 115–25.
  • 2
    Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 1987; 107: 725–31.
  • 3
    Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43: 1089–134.
  • 4
    Steere AC, Angelis SM. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum 2006; 54: 3079–86.
    Direct Link:
  • 5
    Seinost G, Dykhuizen DE, Dattwyler RJ, Golde WT, Dunn JJ, Wang IN, et al. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun 1999; 67: 3518–24.
  • 6
    Wang IN, Dykhuizen DE, Qiu W, Dunn JJ, Bosler EM, Luft BJ. Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 1999; 151: 15–30.
  • 7
    Wormser GP, Liveris D, Nowakowski J, Nadelman RB, Cavaliere LF, McKenna D, et al. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J Infect Dis 1999; 180: 720–5.
  • 8
    Liveris D, Varde S, Iyer R, Koenig S, Bittker S, Cooper D, et al. Genetic diversity of Borrelia burgdorferi in Lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol 1999; 37: 565–9.
  • 9
    Wang G, Ojaimi C, Iyer R, Saksenberg V, McClain SA, Wormser GP, et al. Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice. Infect Immun 2001; 69: 4303–12.
  • 10
    Wang G, Ojaimi C, Wu H, Saksenberg V, Iyer R, Liveris D, et al. Disease severity in a murine model of Lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strains. J Infect Dis 2002; 186: 782–91.
  • 11
    Lagal V, Postic D, Ruzic-Sabljic E, Baranton G. Genetic diversity among Borrelia strains determined by single-strand conformation polymorphism analysis of the ospC gene and its association with invasiveness. J Clin Microbiol 2003; 41: 5059–65.
  • 12
    Lagal V, Portnoi D, Faure G, Postic D, Baranton G. Borrelia burgdorferi sensu stricto invasiveness is correlated with OspC-plasminogen affinity. Microbes Infect 2006; 8: 645–52.
  • 13
    Bunikis J, Garpmo U, Tsao J, Berglund J, Fish D, Barbour AG. Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in Europe. Microbiology 2004; 150: 1741–55.
  • 14
    Dolan MC, Piesman J, Schneider BS, Schriefer M, Brandt K, Zeidner NS. Comparison of disseminated and nondisseminated strains of Borrelia burgdorferi sensu stricto in mice naturally infected by tick bite. Infect Immun 2004; 72: 5262–66.
  • 15
    Ojaimi C, Mulay V, Liveris D, Iyer R, Schwartz I. Comparative transcriptional profiling of Borrelia burgdorferi clinical isolates differing in capacities for hematogenous dissemination. Infect Immun 2005; 73: 6791–802.
  • 16
    Alghaferi MY, Anderson JM, Park J, Auwaerter PG, Aucott JN, Norris DE, et al. Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: lack of correlation with invasive and noninvasive genotypes. J Clin Microbiol 2005; 43: 1879–84.
  • 17
    Jones KL, Glickstein LJ, Damle N, Sikand VK, McHugh G, Steere AC. Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease. J Clin Microbiol 2006; 44: 4407–13.
  • 18
    Wormser GP, Brisson D, Liveris D, Hanincova K, Sandigursky S, Nowakowski J, et al. Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis 2008; 198: 1358–64.
  • 19
    Hanincova K, Liveris D, Sandigursky S, Wormser GP, Schwartz I. Borrelia burgdorferi sensu stricto is clonal in patients with early Lyme borreliosis. Appl Environ Microbiol 2008; 74: 5008–14.
  • 20
    Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep 1997; 46: 1–55.
  • 21
    Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995; 44: 590–1.
  • 22
    Steere AC, Green J, Schoen RT, Taylor E, Hutchinson GJ, Rahn DW, et al. Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med 1985; 312: 869–74.
  • 23
    Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ. Treatment of late Lyme borreliosis: randomized comparison of ceftriaxone and penicillin. Lancet 1998; 1191–4.
  • 24
    Steere AC, Levin RE, Molloy PJ, Kalish RA, Abraham JH III, Liu NY, et al. Treatment of Lyme arthritis. Arthritis Rheum 1994; 37: 878–88.
    Direct Link:
  • 25
    Shin JJ, Glickstein LJ, Steere AC. High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory Lyme arthritis. Arthritis Rheum 2007; 56: 1325–35.
    Direct Link:
  • 26
    Steere AC, Klitz W, Drouin EE, Falk BA, Kwok WW, Nepom GT, et al. Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J Exp Med 2006; 203: 961–71.
  • 27
    Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215: 403–10.
  • 28
    Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL. GenBank. Nucleic Acids Res 2006; 34: D16–20.
  • 29
    Vincze T, Posfai J, Roberts RJ. NEBcutter: a program to cleave DNA with restriction enzymes. Nucleic Acids Res 2003; 31: 3688–91.
  • 30
    Snydman DR, Schenkein DP, Berardi VP, Lastavica CC, Pariser KM. Borrelia burgdorferi in joint fluid in chronic Lyme arthritis. Ann Intern Med 1986; 104: 798–800.
  • 31
    Schmidli J, Hunziker T, Moesli P, Schaad UB. Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis. J Infect Dis 1988; 158: 905–6.
  • 32
    Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994; 330: 229–34.
  • 33
    Qiu WG, Bruno JF, McCaig WD, Xu Y, Livey I, Schriefer ME, et al. Wide distribution of a high-virulence Borrelia burgdorferi clone in Europe and North America. Emerg Infect Dis 2008; 14: 1097–104.
  • 34
    Cadavid D, Pachner AR, Estanislao L, Patalapati R, Barbour AG. Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice. Infect Immun 2001; 69: 3389–97.
  • 35
    Cadavid D, Pennington PM, Kerentseva TA, Bergstrom S, Barbour AG. Immunologic and genetic analyses of VmpA of a neurotropic strain of Borrelia turicatae. Infect Immun 1997; 65: 3352–60.
  • 36
    Pennington PM, Allred CD, West CS, Alvarez R, Barbour AG. Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease. Infect Immun 1997; 65: 285–92.
  • 37
    Pennington PM, Cadavid D, Barbour AG. Characterization of VspB of Borrelia turicatae, a major outer membrane protein expressed in blood and tissues of mice. Infect Immun 1999; 67: 4637–45.
  • 38
    Carlson D, Hernandez J, Bloom BJ, Coburn J, Aversa JM, Steere AC. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment–resistant Lyme arthritis. Arthritis Rheum 1999; 42: 2705–9.
    Direct Link:
  • 39
    Drouin EE, Glickstein LJ, Steere AC. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato. J Autoimmun 2004; 23: 281–92.
  • 40
    Chen J, Field JA, Glickstein L, Molloy PJ, Huber BT, Steere AC. Association of antibiotic treatment–resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum 1999; 42: 1813–22.
    Direct Link:
  • 41
    Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998; 281: 703–6.
  • 42
    Drouin EE, Glickstein L, Kwok WW, Nepom GT, Steere AC. Searching for borrelial T cell epitopes associated with antibiotic-refractory Lyme arthritis. Mol Immunol 2008; 45: 2323–32.
View Full Article (HTML) Get PDF (92K)